We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+3.72%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$18.7B
AUM Growth
+$362M
(+2%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
44.6%
Holding
254
New
8
Increased
16
Reduced
110
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$69.2M |
| 2 |
UnitedHealth
UNH
|
+$23.6M |
| 3 |
Union Pacific
UNP
|
+$22.1M |
| 4 |
RH
RH
|
+$7.93M |
| 5 |
Enterprise Products Partners
EPD
|
+$7.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$58.2M |
| 2 |
Apple
AAPL
|
+$20.5M |
| 3 |
Philip Morris
PM
|
+$20.4M |
| 4 |
Oracle
ORCL
|
+$16.3M |
| 5 |
Coca-Cola
KO
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 31.82% |
| 2 | Financials | 16.56% |
| 3 | Energy | 15.53% |
| 4 | Technology | 10.03% |
| 5 | Healthcare | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
26
Novo Nordisk
NVO
$228B
| $219M | 1.17% |
10,222,782
-347,122
| -3% | -$7M |
|
27
Blackrock
BLK
$168B
| $218M | 1.17% |
516,501
-6,320
| -1% | -$2.52M |
|
28
Walt Disney
DIS
$171B
| $217M | 1.16% |
2,038,026
-44,518
| -2% | -$4.87M |
|
29
Abbott
ABT
$188B
| $213M | 1.14% |
4,379,037
-131,297
| -3% | -$5.94M |
|
|
30
Union Pacific
UNP
$174B
| $208M | 1.11% |
1,905,599
+202,819
| +12% | +$22.1M |
|
31
Alphabet (Google) Class C
GOOG
$4.1T
| $195M | 1.04% |
4,297,240
-13,820
| -0.3% | -$633K |
|
32
Merck
MRK
$322B
| $191M | 1.02% |
3,117,063
-29,632
| -0.9% | -$1.8M |
|
33
American Express
AXP
$223B
| $191M | 1.02% |
2,262,638
-59,529
| -3% | -$4.71M |
|
34
Kraft Heinz
KHC
$32.8B
| $184M | 0.98% |
2,147,669
-7,758
| -0.4% | -$703K |
|
35
RTX Corp
RTX
$291B
| $178M | 0.95% |
2,316,679
-52,812
| -2% | -$3.96M |
|
36
Visa
V
$702B
| $175M | 0.93% |
1,864,951
+32,932
| +2% | +$3.06M |
|
|
PX
37
DELISTED
Praxair Inc
PX
| $164M | 0.87% |
1,235,358
-34,571
| -3% | -$4.43M |
|
38
Estee Lauder
EL
$30.4B
| $154M | 0.82% |
1,602,609
-31,989
| -2% | -$2.94M |
|
39
ConocoPhillips
COP
$144B
| $145M | 0.77% |
3,294,869
-92,872
| -3% | -$4.33M |
|
40
S&P Global
SPGI
$124B
| $143M | 0.77% |
982,087
-20,674
| -2% | -$2.87M |
|
41
Novartis
NVS
$302B
| $121M | 0.64% |
1,611,831
-37,841
| -2% | -$2.68M |
|
42
AB InBev
BUD
$164B
| $120M | 0.64% |
1,086,459
+22,252
| +2% | +$2.55M |
|
43
Canadian Pacific Kansas City
CP
$81.1B
| $114M | 0.61% |
3,530,825
-78,235
| -2% | -$2.43M |
|
44
Automatic Data Processing
ADP
$109B
| $111M | 0.59% |
1,083,334
-25,885
| -2% | -$2.62M |
|
45
Occidental Petroleum
OXY
$55.8B
| $108M | 0.57% |
1,798,137
-224,162
| -11% | -$13.7M |
|
46
Plains All American Pipeline
PAA
$17.5B
| $98.6M | 0.53% |
3,752,143
-14,950
| -0.4% | -$414K |
|
47
Intercontinental Exchange
ICE
$87.4B
| $96.5M | 0.52% |
1,463,341
-21,449
| -1% | -$1.32M |
|
|
48
UnitedHealth
UNH
$382B
| $95.7M | 0.51% |
516,190
+134,546
| +35% | +$23.6M |
|
|
TFCFA
49
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $89M | 0.48% |
3,139,048
-225,375
| -7% | -$6.48M |
|
50
Wells Fargo
WFC
$254B
| $87.7M | 0.47% |
1,582,071
+35,652
| +2% | +$1.91M |
|
Similar funds
HF
Fayez Sarofim & Co's Q2 2017 Portfolio in Review
As of Q2 2017, Fayez Sarofim & Co held 254 positions worth $18.7B, up 2% from $18.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Fayez Sarofim & Co's Q2 2017 filing shows 8 new, 16 increased, 110 reduced and 10 closed positions. Its largest new stake was RH: 150,000 shares worth $9.68M. The largest sale was Target, an estimated $58.2M.
By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, down from 32% a quarter earlier, followed by Financials and Energy.
- Fayez Sarofim & Co's largest Q2 2017 buy was RH: 150,000 shares worth $9.68M.
- Fayez Sarofim & Co added most to Microsoft in Q2 2017, an estimated $69.2M increase.
- Fayez Sarofim & Co's biggest Q2 2017 reduction was Target, cutting an estimated $58.2M.
- Fayez Sarofim & Co fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2017, selling an estimated $9.81M.
- Fayez Sarofim & Co's ten largest holdings make up 45% of its $18.7B portfolio in Q2 2017.
- Fayez Sarofim & Co opened 8 new positions and closed 10 in Q2 2017.
- Fayez Sarofim & Co's portfolio value rose 2% quarter-over-quarter to $18.7B.
Based on Fayez Sarofim & Co's 13F filing for Q2 2017, filed 11 Aug 2017.